The fight against aging: a new approach to an old problem
"Experts have long known that p38MAPK is involved in the development of inflammatory diseases, and clinical trials of pharmacological methods to limit its activity have already begun," notes the lead author of the work D.Bulavin. "Probably, similar methods can be used in the fight against aging."
23.07.2009